Alterna tirzepatide: understanding this weight-loss treatment in the UK

Step 1: Understanding what tirzepatide actually does in the body

Tirzepatide belongs to a class of medicines that mimic hormones released naturally after eating. What makes it distinct is the dual mechanism: it activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. Stimulating both pathways slows gastric emptying, reduces appetite, and improves how the body handles blood sugar. In practical terms, many people find they feel full more quickly and stay satisfied for longer between meals.

The NHS medicine page for tirzepatide gives a clear overview of how the medicine works and what to expect. It's worth reading before your consultation, not to self-diagnose but to arrive with better questions. A question our prescribers hear most weeks is whether the dual mechanism makes tirzepatide meaningfully more effective than single-pathway options, the SURMOUNT-5 head-to-head trial, published in the New England Journal of Medicine in 2025, found that tirzepatide produced greater average weight reduction than semaglutide 2.4 mg over 72 weeks.

Treatment begins at 2.5 mg (a dose chosen for tolerability rather than therapeutic effect) and is titrated upward by the prescriber, typically in four-week steps, through 5, 7.5, 10, 12.5, and 15 mg. The pace is set clinically, not by the calendar alone. Your body's response, and any side effects, inform the process.

Step 2: Why 'alterna tirzepatide' doesn't describe a separate UK product

No licensed alternative brand of tirzepatide exists in the UK for weight management. Mounjaro is the only authorised product. The search phrase 'alterna tirzepatide' surfaces for a few reasons: some people are looking for a cheaper or generic version, others are comparing different weight-loss injections to decide which suits them, and some are trying to understand whether a product they've seen advertised online is the same thing. It is worth being direct on this point.

Generic tirzepatide is not approved for supply in the UK. Compounded or unlicensed versions of tirzepatide are not legal routes to treatment under UK medicines law for this indication. If you've encountered a seller claiming to offer 'alternative' tirzepatide outside the licensed supply chain, that is a significant red flag. The MHRA has warned publicly about counterfeit weight-loss pens (some containing entirely different substances, including insulin) and enforcement operations in 2025 seized approximately 20 million doses of illegally traded weight-loss medicines worth around £45 million. The safest check is simple: verify any online pharmacy on the GPhC pharmacy register. Registered pharmacies are subject to inspection and professional standards; unregistered sellers are not.

If you're comparing tirzepatide to other licensed options, licensed alternatives to Mounjaro do exist, semaglutide (Wegovy injection, Wegovy tablets) is the main comparator, working on a single pathway rather than two. If you've already tried Mounjaro and are wondering whether something else might suit you better, our page covering what to consider when looking for an alternative to Mounjaro walks through the options in more detail.

Step 3: Checking whether you're eligible for tirzepatide in the UK

The licensed eligibility criteria for tirzepatide (Mounjaro) in a private setting follow the SmPC: adults aged 18 or over, with a BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related condition such as hypertension, type 2 diabetes, high cholesterol, or obstructive sleep apnoea. A lower BMI threshold may apply for some ethnic backgrounds under UK clinical guidance. BMI alone doesn't determine whether treatment is appropriate; the prescriber reviews your full health picture, current medicines, and any conditions that may affect suitability.

NICE's appraisal of tirzepatide (TA1026, published December 2024) sets out NHS eligibility at a BMI of 35 or above with at least one weight-related comorbidity, with phased rollout criteria that vary by number of qualifying conditions. Private treatment through a regulated service like Mounjaro at nume operates under the broader licensed criteria, not the NHS commissioning thresholds, which means the private route is open to more people. That said, the clinical assessment is real, there are genuine contraindications and conditions that require the prescriber to decline, modify, or monitor treatment carefully.

If cost is part of your thinking, the cost of Mounjaro in the UK varies by dose and provider. It's useful context before you start.

Step 4: Getting tirzepatide through a regulated UK service

The only legal route to tirzepatide for weight management in the UK is via prescription following a clinical assessment. At nume, that process starts with a free consultation, no referral needed, no GP letter, no waiting list. A GPhC-registered Independent Prescriber reads your answers and medical history the same day. Identity is verified with photo ID, and weight is confirmed on a live video call. Those aren't bureaucratic hoops; they're the reason the prescription is clinically sound.

Orders placed before 12pm on a working day, once clinically approved, are dispatched the same day and delivered free the next working day by DPD in plain packaging. There are no subscriptions and no auto-renewals; each repeat supply is re-reviewed by a prescriber. Our clinical team is available for aftercare seven days a week. If you want to explore weight-loss treatment options more broadly before committing to anything, that's a sensible place to start. And if tirzepatide turns out not to be the right fit clinically, a tablet alternative may be worth discussing with your prescriber.